Companies believe AI isn't delivering because technology moves too fast, so they invest in training and agile frameworks. The real, invisible problems are structural: ambiguous decision rights, siloed data ownership, and misaligned employee incentives. Solving for 'speed' when the foundation is broken guarantees failure.

The industry's costly drug development failures are often attributed to clinical issues. However, the root cause is frequently organizational: siloed teams, misaligned incentives, and hierarchical leadership that stifle the knowledge sharing necessary for success.

Martin Shkreli argues that the primary bottleneck in drug development isn't finding new molecules, but the immense inefficiency caused by poor communication, irrational decision-making, and misaligned incentives across numerous human departments. He believes AI's greatest contribution will be optimizing this complex organizational process rather than just improving discovery.

The traditional pharma leadership model focused on minimizing risk through tight, linear control is no longer competitive. The future requires a shift to agile coordination, allowing leaders to reallocate priorities quickly in a data-driven, connected way.

Many leaders fight bureaucracy like an external threat. The real cause is the organization's design: too many layers, functional silos, and distant decision-making. To fix bureaucracy, you must fundamentally change the organizational structure, not just treat symptoms.

Contrary to the popular bottoms-up startup ethos, a top-down approach is crucial for speed in a large organization. It prevents fragmentation that arises from hundreds of teams pursuing separate initiatives, aligning everyone towards unified missions for faster, more coherent progress.

Leaders adopt advanced AI to accelerate innovation but simultaneously stifle employees with traditional, control-oriented structures. This creates a tension where technology's potential is neutralized by a culture of permission-seeking and risk aversion. The real solution is a cultural shift towards autonomy.

The primary bottleneck to organizational speed isn't how fast individuals work; it's decision latency—the time it takes for decisions to be made and flow through the organization. This stems from unclear decision rights, poor communication, or lack of empowerment. Reducing this latency is the key to accelerating engineering and overall business velocity.

When a company repeatedly fails to evolve despite clear data, the root cause is not a faulty process or lack of agility. It's a personnel problem—leaders who are unable or unwilling to make correct decisions. Business agility only makes these blockages transparent; it doesn't solve them.